Back to: FDA Compounding Quality Center of Excellence Annual Conference 2025
Presenter:
Meghan Murphy
Senior Advisor, Director for Research Strategy and Engagement Compounding Quality COE
FDA
Meghan Murphy is currently a Senior Advisor in the Office of Compounding Quality and Compliance, part of the Office of Compliance within FDA’s Center for Drug Evaluation and Research. She is the Director for Research, Strategy, and Engagement for the Compounding Quality Center of Excellence (COE). She leads and is responsible for day to day operations of the research and analysis, annual conference, strategic planning, and outreach efforts for the COE. She previously served as the Acting Associate Director for Risk Science, Intelligence, and Prioritization for the Office of Unapproved Drugs and Labeling Compliance, Center for Drug Evaluation and Research, in the U.S. Food and Drug Administration. Prior to that, Ms. Murphy was a Pharmacologist in the same organization and worked on addressing scientific and regulatory issues concerning marketed unapproved drugs and drugs compounded by pharmacists. She began her career at FDA as a member of the Department of Health and Human Services Emerging Leaders Program. Ms. Murphy obtained a Ph.D. in Pharmacology and an M.A. in Organic Chemistry from the University of North Carolina at Chapel Hill, and a B.S. in Biochemistry from the University of Maryland, Baltimore County.